SOX2 and breast cancer: Hinokitiol led to tumor spheroids shrinkage as inhibited BC stem-like cells self-renewable capacity, suppressed tumor stemness-progression via inhibiting CD44/Nanog/SOX2/Oct4 signaling pathways.